The ROE as of December 2024 (TTM) for Panbela Therapeutics, Inc. (PBLA) is 304.71%

According to Panbela Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is 304.71%. This represents a change of 160.46% compared to the average of 116.99% of the last 4 quarters.

Panbela Therapeutics, Inc. (PBLA) Historical ROE (quarterly & annually)

How has PBLA ROE performed in the past?

The mean historical ROE of Panbela Therapeutics, Inc. over the last ten years is -121.05%. The current 304.71% ROE has changed -351.73% with respect to the historical average. Over the past ten years (40 quarters), PBLA's ROE was at its highest in in the June 2019 quarter at 1.94%. The ROE was at its lowest in in the June 2018 quarter at -2259.09%.

Panbela Therapeutics, Inc. (PBLA) ROE by Quarter and Year

Discovering the peaks and valleys of Panbela Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Panbela Therapeutics, Inc. (PBLA) Average ROE

How has PBLA ROE performed in the past?

The current ROE of Panbela Therapeutics, Inc. (PBLA) is less than than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Panbela Therapeutics, Inc. (PBLA) ROE vs. Peers

How is PBLA’s ROE compared to its peers?

Panbela Therapeutics, Inc.’s ROE is greater than ZyVersa Therapeutics, Inc. (-25512.50%), greater than Sonnet BioTherapeutics Holdings, Inc. (-383.41%), greater than Revelation Biosciences, Inc. (-311.33%), greater than Navidea Biopharmaceuticals, Inc. (-173.56%), less than Altamira Therapeutics Ltd. (783.37%), greater than Palisade Bio, Inc. (-148.31%), greater than Virax Biolabs Group Limited (-115.10%), greater than Quoin Pharmaceuticals, Ltd. (-126.19%), greater than Unicycive Therapeutics, Inc. (-374.14%), greater than Cardio Diagnostics Holdings, Inc. (-258.81%), greater than PaxMedica, Inc. Common Stock (-3167.06%), greater than Blue Water Vaccines, Inc. (-126.11%), greater than Hillstream BioPharma, Inc. (-172.28%), less than Kiora Pharmaceuticals, Inc. (21.31%),

Build a custom stock screener for Panbela Therapeutics, Inc. (PBLA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Panbela Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Panbela Therapeutics, Inc. (PBLA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Panbela Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.